Abstracts - faqs.org

Abstracts

Business, regional

Search abstracts:
Abstracts » Business, regional

Regulators, Fannie Mae OK deal

Article Abstract:

Mortgage giant, Fannie Mae would increase its reserve against risk by billions of dollars, recalculate hedging transactions, and tighten internal controls due to the increasing pressure from regulators to correct serious accounting problems. As per the Office of Federal Housing Enterprise Oversight, Fannie Mae needs to maintain an additional capital cushion equivalent to 30 percent of the company's current minimum capital requirement.

Author: Gordon, Marcy
Publisher: Philadelphia Newspapers, Inc.
Publication Name: Philadelphia Inquirer (PA)
Subject: Business, regional
ISSN: 0885-6613
Year: 2004
Massachusetts, Mortgage Bankers, Real Estate Credit, Mortgage Bankers and Brokers, Mortgage Bankers & Brokers, Mortgage and Nonmortgage Loan Brokers, FNM, Mortgage banks, Hedge funds, Federal National Mortgage Association

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Board moves to require firms to expense all stock options

Article Abstract:

The Financial Accounting Standards Board in the US has made a proposal to require publicly traded companies to record all forms of share-based payments to employees, including employee stock options, as a compensation expense. If approved, the proposal would be effective for the fiscal years beginning after December 15, 2004, and would have severe consequences for profit and executive pay in corporate America.

Author: Gordon, Marcy
Publisher: Philadelphia Newspapers, Inc.
Publication Name: Philadelphia Inquirer (PA)
Subject: Business, regional
ISSN: 0885-6613
Year: 2004
Government regulation (cont), Government regulation, Laws, regulations and rules, Accounting, Employee stock options, Financial Accounting Standards Board, Accounting law, Joint-stock companies, Joint stock companies

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Drug firm settles SEC case on fraud

Article Abstract:

The Securities and Exchange Commission (SEC) filed a suit against Bristol-Myers Squibb Co. in August 2004 and ordered it to pay $150 million to settle allegations of accounting fraud. The SEC sued the company in federal court in Newark, New Jersey, accusing it of manipulating its inventory of drugs to inflate earnings.

Author: Gordon, Marcy
Publisher: Philadelphia Newspapers, Inc.
Publication Name: Philadelphia Inquirer (PA)
Subject: Business, regional
ISSN: 0885-6613
Year: 2004
Pharmaceutical preparations, Company legal issue, Cases, Pharmaceutical industry, Bristol-Myers Squibb Co., United States. Securities and Exchange Commission, BMY

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Management, Company business management, United States, Accounting and auditing
Similar abstracts:
  • Abstracts: Biggest U.S steel company to be sold. Local owner to recast local steel operations. Sales deal for steel company is closer
  • Abstracts: Annuity risks: Regulators are shifting focus to insurance-products sales practices. Playing fairer with fund fees
  • Abstracts: Teamwork and new office take local real estate franchise to the top. Stuck in traffic
  • Abstracts: Centocor wins FDA approval for a third medicine. Tenet trimming some programs to cut expenses
  • Abstracts: SpectaGuard expands with buyout of rival. Unisys plans to acquire PulsePoint. Moyer Packing agrees to be sold
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.